Advertisement
Screener

Carlsmed, Inc. (CARL) Proceeds from Debt, Net of Issuance Costs

1.4 / 5 stars · 2/7 Roast Me

Carlsmed, Inc. Proceeds from Debt, Net of Issuance Costs

Carlsmed, Inc. (CARL) reported Proceeds from Debt, Net of Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-02-25

  • Carlsmed, Inc. proceeds from debt, net of issuance costs for the quarter ending 2024-12-31 was -$25.00K.
  • Carlsmed, Inc. proceeds from debt, net of issuance costs for the quarter ending 2024-09-30 was $0.00.
  • Carlsmed, Inc. proceeds from debt, net of issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Carlsmed, Inc. proceeds from debt, net of issuance costs for fiscal 2024 was $6.21M.
Period endProceeds from Debt, Net of Issuance Costs 3 monthProceeds from Debt, Net of Issuance Costs 6 monthProceeds from Debt, Net of Issuance Costs 9 monthProceeds from Debt, Net of Issuance Costs 12 month
2025-12-31$0.00
10-K · filed 2026-02-25
2024-12-31-$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$25.00K
derived: sum of 2 quarters · filed 2026-02-25
$6.21M
10-K · filed 2026-02-25
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$6.24M
10-Q · filed 2025-11-06
2024-06-30$6.24M
10-Q · filed 2025-08-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orthofix Medical Inc. (OFIX)$0.373B
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
Embecta Corp. (EMBC)United States$0.319B2.10
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16